Cytek Biosciences (CTKB) AGM 2026 summary

Opening remarks and agenda

• Meeting opened by CEO with introductions of directors, executive team, auditors, and legal counsel.

• Agenda included formal business, voting on proposals, and a Q&A session for stockholders.

Board and executive committee updates

• Three Class II directors nominated for election to serve until the 2029 Annual Meeting.

• No stockholder nominations for director candidates were received by the advance notice deadline.

Shareholder proposals

• Non-binding advisory vote on executive compensation for the year ended December 31, 2025, was presented.